Skip to content

Evaluation of Hypoxia in patients with frozen shoulder and of its change after transcatheter arterial embolization

Evaluation of Hypoxia in patients with frozen shoulder and of its change after transcatheter arterial embolization - Hypoxia in frozen shoulder before and after embolization

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025551
Enrollment
30
Registered
2017-01-06
Start date
2017-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Adhesive capsulitis (frozen shoulder)

Interventions

Sponsors

Edogawa Hospital
Lead Sponsor
1.Department of Nuclear medicine, International Medical center, Saitama Medical University 2.Department of orthopedic syrgery, School of medicine, Toho University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who were diagnosed as adhesive capsulitis 2.having moderate to severe pain (Numerical rating score:NRS=5 or more) 3.age 20<, 80> 4.Shoulder surgeon judged that transcatheter arterial micro-shunt embolization is applicable for. 5.Patients who maintain major organ (bone marrow, heart, liver, lung, kidney) function. 6.Patients without diabetes mellitus 7.Provided written informed consent to undergo the procedure.

Exclusion criteria

Exclusion criteria: 1.Patients who have undergoing or previous pathology in opposite shoulder 2.Patients with rotator cuff full thickness tear detected by MRI 3.Pregnant female 4.Prior shoulder surgery 5.Mental illness 6.Rheumatoid arthritis or Neoplasm 7.Patients who has been diagnosed as diabetes mellitus 8.Patients who received intra-articular steroid injection or who received oral steroi during last one months. 9.Patients who was decided not to be appropriate for this trial by physician

Design outcomes

Primary

MeasureTime frame
SUV-max ratio of FMISO-PET examination between affected side and unaffected side in region of interest before treatment

Secondary

MeasureTime frame
The change of SUV-max ratio of FMISO-PET examination after transcatheter arterial embolization SUV-max ratio of FDG-PET examination in region of interest The change of SUV-max ratio of FDG-PET after embolization MRI imaging scoring before and after embolziation Pain VAS score before and after treatment The change of serum marker before and after treatment Range of motion before and after treatment

Countries

Japan

Contacts

Public ContactYuji Okuno

Edogawa Hospital Musculoskeletal Intervention Center

okuno@edogawa.or.jp03-3673-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026